https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
g a high cost saver; antidepressant count and all-cause inpatient and outpatient visits in the baseline period were inversely associated with cost savings. CONCLUSIONS Use of a pharmacogenetic assay was associated with cost-savings in the database of a large commercial insurer. Patients with bipolar disorder were more likely to be high cost savers than individuals with other mood and anxiety disorders. FUNDING ACKNOWLEDGEMENTS Genomind.The existence of bipolar disorder (BD) among teenagers is controversial. The study aims to r
Like
Comment
Share
